Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-19T08:37:44.715Z Has data issue: false hasContentIssue false
  • English
  • Français

The Role of MRI and Nerve Root Biopsy in the Diagnosis of Neurosarcoidosis

Published online by Cambridge University Press:  02 December 2014

Fraser G.A. Moore ,
Frederick Andermann ,
John Richardson ,
Donatella Tampieri  and
Robert Giaccone
Fraser G.A. Moore
Affiliation:
Department of Neurology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
Frederick Andermann
Affiliation:
Department of Neurology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
John Richardson
Affiliation:
Department of Neurology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
Donatella Tampieri
Affiliation:
Department of Neurology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
Robert Giaccone
Affiliation:
Department of Neurology, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives:

Neurological involvement occurs in 5-15% of patients with sarcoidosis and isolated “neurosarcoidosis” occurs in less than 1% of all cases. Classical clinical presentations have been described, such as bilateral facial palsy, but often the disease presents insidiously with varied signs and symptoms. We present a patient who required biopsy of a lumbar nerve root for diagnosis of chronic, progressive neurosarcoidosis and review the literature with an emphasis on diagnosis.

Methods:

We have reviewed a patient who presented with signs and symptoms related to infiltration of her meninges and nerve roots by sarcoidosis. All pertinent history and physical information was taken from interviews with the patient and review of her chart. Laboratory, radiographic, and pathological investigations are presented.

Results and conclusions:

A high index of suspicion is required for the diagnosis of neurosarcoidosis. Gadolinium-enhanced MRI is useful but the findings are often nonspecific, and there should be a low threshold for biopsy whenever the diagnosis is considered.

Résumé:

RÉSUMÉ:

Le rôle de la RMN et de la biopsie nerveuse dans le diagnostic de la neurosarcoïse.

Objectifs:

Cinq à 15% des patients atteints de sarcoïse ont une atteinte neurologique et moins de un pour cent des patients ont une "neurosarcoïse". Des modes de présentation clinique classiques ont été décrits, telle la paralysie faciale bilatérale, mais souvent la maladie commence insidieusement par des signes et des symptômes variés. Nous présentons le cas d'un patient chez qui on a dûir recours à une biopsie d'une racine nerveuse lombaire pour poser le diagnostic de neurosarcoïse progressive chronique et nous revoyons la littérature en mettant l'emphase sur le diagnostic.

Méthodes:

Nous avons revu le cas d'un patient qui avait consulté pour des signes et des symptômes en relation avec une infiltration des méninges et de racines nerveuses par la sarcoïse. Toute l'information pertinente sur l'histoire et l'examen physique a été extraite d'entrevues avec la patiente et de son dossier médical. Les investigations biochimiques, radiologiques et anatomopathologiques sont présentées. Résultats et

Conclusions:

Le diagnostic de neurosarcoïse requiert un fort soupçon que cette maladie soit en cause. La RMN avec rehaussement par le gadolinium est utile, mais les constatations sont souvent non spécifiques. Quand ce diagnostic est considéré, on ne doit pas hésiter à procéder à une biopsie.

Type
Case Report
Information
Canadian Journal of Neurological Sciences , Volume 28 , Issue 4 , November 2001 , pp. 349 - 353
Copyright
Copyright © The Canadian Journal of Neurological 2001

References

1. Stern, BJ, Krumholz, A, Johns, C, Scott, P, Nissim, J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985;42:909–917.CrossRefGoogle ScholarPubMed
2. Delaney, P. Neurological manifestations of sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977;87:336–345.Google Scholar
3. Lower, EE, Broderick, JP, Brott, TG, Baughman, RP. Diagnosis and management of neurological sarcoidosis. Arch Int Med 1997;157:1864–1868.Google Scholar
4. Scott, TF. Neurosarcoidosis: Progress and clinical aspects. Neurology 1993;43:8–12.Google Scholar
5. Chapelon, C, Ziza, JM, Piette, JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine 1990;69(5):261–276.CrossRefGoogle ScholarPubMed
6. Silberberg, DH. Sarcoidosis of the nervous system. In: Aminoff, MJ ed. Neurology and General Medicine. New York: Churchill Livingstone, 1995.Google Scholar
7. Jallo, GI, Zagzag, D, Lee, M, et al. Intraspinal sarcoidosis: diagnosis and management. Surg Neurol 1997;48:514–521.Google Scholar
8. Zajicek, J. Sarcoidosis of the cauda equina: a report of three cases. J Neurol 1990;237:424–426.Google Scholar
9. Ku, A, Lachmann, E, Tunkel, R, Nagler, W. Neurosarcoidosis of the conus medullaris and cauda equina presenting as paraparesis: case report and literature review. Paraplegia 1996;34:116–120.Google Scholar
10. Lewis, PJ, Salama, A. Uptake of Fluorine-18-Fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994;35:1647–1649.Google Scholar
11. Yamada, Y, Uchida, Y, Tatsumi, K, et al. Fluorine-18-Fluorodeoxy-glucose and Carbon-11-Methionine evaluation of lymphadeno-pathy in sarcoidosis. J Nucl Med 1998;39:1160–1166.Google Scholar
12. Alavi, A, Buchpiguel, CA, Loessner, A. Is there a role for FDG PET imaging in the management of patients with sarcoidosis? J Nucl Med 1994;35:1650–1652.Google Scholar
13. Dale, JC, O’Brien, JF. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc 1999;74:535.CrossRefGoogle Scholar
14. Mankodi, AK, Desai, AD, Mathur, RS, Poncha, FF. Diagnostic role of Mantoux test site biopsy in neurosarcoidosis. Neurology 1998;51:1216–1218.Google Scholar
15. Sherman, JL, Stern, BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. Am J Radiol 1990;155:1293–1301.Google Scholar
16. Lexa, FJ, Grossman, RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. Am J Neuroradiol 1994;15:973–982.Google Scholar
17. Christoforidis, GA, Spickler, EM, Recio, MV, Mehta, BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. Am J Neuroradiol 1999;20:655–669.Google ScholarPubMed
18. Junger, SS, Stern, BJ, Levine, SR, et al. Intramedullary spinal sarcoidosis: clinical and magnetic imaging characteristics. Neurology 1993;43:333–337.CrossRefGoogle ScholarPubMed
19. Dumas, JL, Valeyre, D, Chapelon-Abric, C, et al. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy. Radiology 2000;214:411–420.Google Scholar
20. Agbogu, BN, Setn, BJ, Sewell, C, Yang, G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995;52:875–879.Google Scholar
21. Stern, BJ, Schonfeld, SA, Sewell, C, et al. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992;49:1065–1072.CrossRefGoogle ScholarPubMed